Medford, Oregon

Velocity Clinical Research, Medford

Velocity’s research site in Medford was founded in 1997 as the Clinical Research Institute of Southern Oregon, and acquired by Velocity in 2017. As an independent research facility, our Medford site has long been a leading respiratory clinical research center, with a core focus on Allergy, Asthma and COPD clinical studies. The site is often one of the top enrolling sites nationally for these respiratory indications, and also has extensive expertise in atopic dermatitis and vaccine studies.

Located just 10 minutes from the Medford airport, the site is easily accessible and has free parking. With a population of 216,000 in Metropolitan Medford, another 300,000 residents in the surrounding counties, and a robust database of potential study participants, our Medford site is capable of recruiting thousands to our trials. With more than 8,500 square-feet of dedicated research space, our staff can efficiently and effectively conduct multiple concurrent studies. All trials are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Velocity Medford team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.

Velocity Clinical Research, Medford
3121 Signature Court, Medford, OR 97504

Phone: (541) 858-1018

Email: info@velocityclinical.com

Find a Clinical Trial in Medford
Use the dropdown to browse current studies in Medford.

Follow Velocity on Facebook for company updates and more.

Medford-Oregon-Velocity-Clinical-Research-Site

About Velocity Clinical Research

155,000+ people have a joined a study at Velocity

Many people enjoy the study experience and have joined several clinical trials at Velocity.

Velocity has decades of research experience

With sites that were established as long ago as 1986, Velocity has experts who have supported clinical trials for decades.

Velocity studies are led by healthcare professionals

All clinical trials conducted at Velocity are overseen by the U.S. Food and Drug Administration (FDA).

Our experienced research team in Medford

Every clinical trial is overseen by a Principal Investigator – a physician who is responsible for the rights, safety and welfare of the study participants. All physicians at Velocity are board certified in their specialty area(s) and all research staff is trained in clinical research regulations, including GCP and HIPAA. Our clinical research team in Medford is dedicated to conducting quality research in a professional and caring environment.

  • Sarah Smiley, DO

    Medical Director, Principal Investigator
    Sarah Smiley, DO is board certified in both Internal Medicine as well as Hospice and Palliative Care. Dr. Smiley attended medical school at Texas Christian Univeristy and the University of North Texas Health Science Center, and completed her residency in Internal Medicine at the University of Texas at Austin Dell.

  • Danuel Hamlin, BS, CCRC, AE-C

    Site Director
    Danuel Hamlin, BS, CCRC, AE-C has been a Clinical Research Coordinator at Velocity Clinical Research in Medford (formerly Crisor) since 2001 and the Clinical Research Director since 2004. Dan oversees day-to-day operations including training for all staff and site preparation for sponsor and regulatory agency audits. His positive leadership has helped build a strong team focused on serving patients and working with clinical research sponsors to provide excellent, perfectly executed clinical trials. Dan has a background in sports medicine and played football at Southern Oregon University in Ashland, Oregon.

Learn More About Participating in a Clinical Trial

Liver Illustration with blog title, All About Liver Disease - Terminology, Early Detection, Symptoms and and Long Term Risk

All About Liver Disease

Liver disease is a growing concern across the globe, especially in the United States, where the prevalence of conditions like Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis … Read more

What is Informed Consent

What is Informed Consent?

Joining a clinical trial is an important decision. Most participants come to the clinic with questions about clinical trials and what joining one could mean. This is why every study … Read more

Clinical Trial Phases What Happens in Phase 1, 2, 3 and 4

Clinical Trial Phases: What Happens in Phase 1, 2, 3 and 4?

Clinical trials are research studies of medications, vaccines, medical devices, procedures, diagnostics (tests), and other health-related products. These studies involve participants (also known as patients, volunteers, or subjects) to determine … Read more

Maryann - research study participant testimonial

Participant Story: Maryann, a Research Study Participant at Velocity

What led you to participate in a research study? I saw a roadside poster near the university in my neighborhood [for a vaccine study] and called Velocity. My first experience … Read more

Complete the form to start your clinical trial journey in Medford

Why join a clinical trial?

  • Help advance medicine
  • Learn about potential new medicines in development
  • Get study-related medical exams at no cost
  • Receive compensation for participating (available amounts may differ for each study)

After you submit your info, a Velocity staff member will review your info. They will contact you to talk about the study, or others that may be right for you.

Health insurance is generally not needed to join a clinical trial.

Remember, there is never an obligation to join — we're here to help you make the best decision.

Submit your info

Sponsors and CROs

From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health. Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, trust Velocity.

clinical research team

It all starts with people like you.

Without clinical trial participants, it would not be possible to create new medicines, treatments, and cures.